Severance Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02755753
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

YongChan Lee

Active Ingredients

Drugs in Phase 4 Trials (2)

lansoprazole (prevacid) (1 trial)

rebamipide (1 trial)

Drugs in Other Trials (4)

angelica (1 trial)

cinnamon (1 trial)

cnidium rhizome (1 trial)

ginseng (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophagitis (Phase 4)

Esophagitis, Peptic (Phase 4)

Gastroesophageal Reflux (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6